OleaPharma : Clôture définitive de nos activités

Silicone is the first choice of dermatologists and plastic surgeons worldwide.
A recent publication by the International Advisory Panel on Scar Management (International Consultative Committee for the management of scars) recommends the use of silicone for the first line treatment of different types of scars.


The efficacy and safety of silicone for the treatment and prevention of scars are confirmed by many studies.

Kelo-cote, a mixture of silicones and long chain polymers of silicon dioxide which, after application of a thin and uniform layer dry quickly to form a gas permeable film, waterproof and flexible. This film adheres to the stratum corneum (dead cell layer the outermost epidermis) creating a protective barrier against chemical, physical and microbial invasion of the scar and contribute to hydration. This creates an environment that allows the scar aging using normalized collagen synthesis cycles, and improves the physiological and cosmetic appearance of the scar.

Kelo-cote, with its patented cross-linking technology, is a silicone-based products indicated for the treatment of scars that have undergone clinical trials in more patients - more than 1,800 patients have participated in clinical trials whose results were published.


For the treatment of hypertrophic scars and keloids, Kelo-cote®contribue the significant reduction in all key measures of scars evaluated on the Vancouver Scar Scale (LCA).


Doctors have estimated that the overall effectiveness was "very good" or "good" in 82.6% of cases, and patients rated it "very good" or "good" in 81.4% of cases . Efficacy was assessed by measuring the typical symptoms associated with scars: the difference in color from the surrounding skin, flexibility, raising, itching and pain / sensitivity.